Chemistry:Melevodopa

From HandWiki

Melevodopa, also known as levodopa methyl ester (LDME) and sold under the brand name Levomet, is a dopaminergic agent. It is the methyl ester of levodopa.[1] It is used in oral tablet form as an effervescent prodrug with 250 times the water solubility of tablet levodopa.[2][3] In combination with carbidopa, as melevodopa/carbidopa (brand name Sirio), it is approved for use in the treatment of Parkinson's disease.[4][5]

See also

References

  1. Dictionary of Alkaloids with CD-ROM. CRC Press. 2010. p. 103. ISBN 978-1-4200-7770-4. https://books.google.com/books?id=mynNBQAAQBAJ&pg=PA103. Retrieved 28 September 2024. 
  2. "Available and emerging treatments for Parkinson's disease: a review". Drug Design, Development and Therapy 5: 241–254. 2011. doi:10.2147/DDDT.S11836. PMID 21607020. 
  3. "Factors associated with motor fluctuations and dyskinesia in Parkinson Disease: potential role of a new melevodopa plus carbidopa formulation (Sirio)". Clin Neuropharmacol 33 (4): 198–203. July 2010. doi:10.1097/WNF.0b013e3181de8924. PMID 20414107. 
  4. "Melevodopa/carbidopa". AdisInsight. Springer Nature Switzerland AG. 23 September 2021. https://adisinsight.springer.com/drugs/800010247. 
  5. "Melevodopa: Uses, Interactions, Mechanism of Action". 1 April 2015. https://go.drugbank.com/drugs/DB13313.